BR112014001039A2 - parasita vivo pertencente ao gênero plasmodium, composição imunogênica, vacina contra a malária, uso de um parasita e método para imunizar um paciente contra malária - Google Patents

parasita vivo pertencente ao gênero plasmodium, composição imunogênica, vacina contra a malária, uso de um parasita e método para imunizar um paciente contra malária

Info

Publication number
BR112014001039A2
BR112014001039A2 BR112014001039A BR112014001039A BR112014001039A2 BR 112014001039 A2 BR112014001039 A2 BR 112014001039A2 BR 112014001039 A BR112014001039 A BR 112014001039A BR 112014001039 A BR112014001039 A BR 112014001039A BR 112014001039 A2 BR112014001039 A2 BR 112014001039A2
Authority
BR
Brazil
Prior art keywords
parasite
malaria
immunize
immunogenic composition
living
Prior art date
Application number
BR112014001039A
Other languages
English (en)
Inventor
Vaquero Catherine
Essénia Lawson-Hogban Nadou
Menard Robert
Mecheri Salaheddine
Briquet Sylvie
Original Assignee
Pasteur Institut
Université Pierre Et Marie Curie (Paris 6)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Université Pierre Et Marie Curie (Paris 6) filed Critical Pasteur Institut
Publication of BR112014001039A2 publication Critical patent/BR112014001039A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112014001039A 2011-07-20 2012-07-19 parasita vivo pertencente ao gênero plasmodium, composição imunogênica, vacina contra a malária, uso de um parasita e método para imunizar um paciente contra malária BR112014001039A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1156571A FR2978048B1 (fr) 2011-07-20 2011-07-20 Composition vaccinale contre le paludisme
PCT/FR2012/051722 WO2013011247A1 (fr) 2011-07-20 2012-07-19 Plasmodium atténué ayant le gène hmgb2 désactivé comme vaccin

Publications (1)

Publication Number Publication Date
BR112014001039A2 true BR112014001039A2 (pt) 2017-02-14

Family

ID=46724494

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014001039A BR112014001039A2 (pt) 2011-07-20 2012-07-19 parasita vivo pertencente ao gênero plasmodium, composição imunogênica, vacina contra a malária, uso de um parasita e método para imunizar um paciente contra malária

Country Status (10)

Country Link
US (1) US20140154289A1 (pt)
EP (1) EP2734270A1 (pt)
JP (1) JP2014520563A (pt)
CN (1) CN103842029A (pt)
AU (1) AU2012285600A1 (pt)
BR (1) BR112014001039A2 (pt)
CA (1) CA2841164A1 (pt)
FR (1) FR2978048B1 (pt)
MX (1) MX2014000727A (pt)
WO (1) WO2013011247A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014025823A8 (pt) * 2012-04-17 2017-07-25 Inst De Medicina Molecular Parasitas plasmodium de roedores utilizados como plataformas para uma vacina contra a malária á base de organismos inteiros
US10898564B2 (en) * 2016-07-18 2021-01-26 Institut Pasteur Plasmodium with histamine releasing factor (HRF) deficiency for use as a vaccine
JP6871729B2 (ja) * 2016-12-06 2021-05-12 シスメックス株式会社 マラリア原虫に感染した赤血球の検出方法及び血液分析装置
US11524060B2 (en) 2018-04-26 2022-12-13 Guangzhou Cas Lamvac Biotech Co., Ltd Attenuation system and use thereof
CN108635576B (zh) * 2018-08-01 2020-09-29 黑龙江八一农垦大学 一种免疫联合佐剂及其制备方法与应用
KR102169664B1 (ko) * 2019-02-26 2020-10-23 원광대학교산학협력단 열대열말라리아원충 유래의 EF-1α 재조합 단백질을 유효성분으로 포함하는 말라리아 예방용 백신 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0316423A (pt) 2002-11-20 2005-10-11 Sanaria Inc Método para prevenção de malária

Also Published As

Publication number Publication date
FR2978048B1 (fr) 2014-10-10
CN103842029A (zh) 2014-06-04
US20140154289A1 (en) 2014-06-05
FR2978048A1 (fr) 2013-01-25
CA2841164A1 (fr) 2013-01-24
AU2012285600A1 (en) 2014-03-06
MX2014000727A (es) 2014-08-21
WO2013011247A1 (fr) 2013-01-24
EP2734270A1 (fr) 2014-05-28
JP2014520563A (ja) 2014-08-25

Similar Documents

Publication Publication Date Title
BR112014001039A2 (pt) parasita vivo pertencente ao gênero plasmodium, composição imunogênica, vacina contra a malária, uso de um parasita e método para imunizar um paciente contra malária
BR112013010288A2 (pt) método de produção de uma vacina para proteger um animal de biótipo de microrganismo, vacina para proteger um animal de um biótipo de microrganismo, método para proteger um animal e método para determinar se um animal foi vacinado
EP2532668A4 (en) OPTICALLY ACTIVE 2-HYDROXY-TETRAHYDROTHIA-PYRIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND THEIR USE IN MEDICAMENT MANUFACTURE
BR112013028273A2 (pt) método para estimular um procedimento médico e artigo
CL2014002674A1 (es) Compósicion inmunogenica que comprende una porcion soluble de una preparacion de celulas enteras de mycoplasma hyopneumoniae (m. hyo); procedimiento para inmunizar; procedimiento de preparacion.
BR112014010658A2 (pt) antígenos e vacinas direcionadas contra enterovírus humano
PL2659035T3 (pl) Włókna hialuronowe, sposób ich wytwarzania i zastosowanie
BR112013030321A2 (pt) composição de vacina, método para preparar a composição de vacina, uso da composição de vacina, método para imunizar um porco, cepa de vacina contra csfv e uso de uma célula no cultivo de uma cepa de vacina contra csfv.
EP2723371A4 (en) VAPOR FORMULATION AGAINST PAPILLOMAVIRUS COMPRISING AN ALUMINUM ADJUVANT, AND PROCESS FOR PRODUCTION THEREOF
IL230855A0 (en) Cabazitaxel formulations and methods for their preparation
BR112013012309A2 (pt) composto, composição, métodos de tratamento e usos de um composto
EP2442826A4 (en) INFLUENZA VACCINE, COMPOSITION, AND METHODS OF USE
PL2575873T3 (pl) Zatężanie i liofilizacja antygenów szczepionkowych grypy
EP2621540A4 (en) SYNTHESIS PRODUCTS OF ANTIGEN CONSENSUS AND VACCINES MADE THEREFROM, AND METHODS OF USING THE SAME TO TREAT MALARIA
IL225972A0 (en) Salts of cocuamine b, a method for their preparation and use
IL236270A0 (en) Cationic lipid vaccine compositions and methods of use
EP2514415A4 (en) TRANSDERMALLY ABSORBED PREPARATION OF ANTI-DEMENTIA MEDICINE
BR112012016048A2 (pt) "exossomas derivados de reticulócitos infectados com plasmodium sp., método para obter os mesmos e usos dos mesmos".
HK1217288A1 (zh) 冬蟲夏草提取液及其製備方法和應用
PL2575872T3 (pl) Zatężanie antygenów szczepionkowych grypy bez liofilizacji
BRPI0822098A2 (pt) Componente para uma vacina contra malária, vacina para malária, processo para a preparação do componente, uso do componente, e, método de tratar um paciente suscetível às infecções por plasmodium
EP2419130A4 (en) MENINGOKOKEN AND PNEUMOKOKKONJUGATIMPFSTOFF AND METHOD OF USE THEREOF
HK1199199A1 (en) Blood stage malaria vaccine
EP2694102A4 (en) PROCESS FOR IMPROVED VACCINE IMMUNOGENICITY
BRPI0918226A2 (pt) composição imunogênica, método para produzir uma composição imunogênica, método para elicitar uma resposta imune contra neisseria, uso da composição imunogênica, e, vacina

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)